Skip Navigation

European Journal of Heart Failure 2008 10(6):556-559; doi:10.1016/j.ejheart.2008.04.012
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Duman, D.
Right arrow Articles by Bilgehan, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Duman, D.
Right arrow Articles by Bilgehan, K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2008 European Society of Cardiology

Serum carbohydrate antigen 125 levels in advanced heart failure: Relation to B-type natriuretic peptide and left atrial volume

Dursun Dumana,*, Fatih Palitb, Ergun Simsekb and Karadag Bilgehanc

a Haydarpasa Numune Training and Research Hospital, Department of Cardiology, Tibbiye Caddesi Kadiköy/Istanbul, Turkey
b Haydarpasa Numune Training and Research Hospital, Department of Internal Medicine Istanbul, Turkey
c University of Istanbul, Cerrahpasa School of Medicine, Department of Cardiology Istanbul, Turkey

* Corresponding author. Tel.: +90 216 640 2061; fax: +90 216 640 2713. E-mail address: drduman{at}excite.com


   Abstract

Aims: To assess the relation between serum levels of carbohydrate antigen 125 (CA 125) and parameters of left ventricular (LV) filling pressure in patients with advanced heart failure (AHF).

Methods: Forty-nine patients (mean age 67±10 years) with LV ejection fraction (EF) ≤0.35 and New York Heart Association (NYHA) class III or IV symptoms of heart failure were enrolled. Left atrial volume indexed to body surface area (LAVI) and the ratio of mitral inflow early diastolic velocity to annulus velocity (E/e) were evaluated with pulsed wave and tissue Doppler. Plasma B-type natriuretic peptide (BNP) was also measured.

Results: The median overall CA 125 value was 44.0 (17.7–140) U/ml. CA 125 above the normal value (<35U/ml) was found in 28 of the 49 patients (57%). Compared to patients with normal CA 125 levels, those with elevated CA 125 had a higher NYHA class and increased serum BNP levels, LAVI and E/e. In multivariate analysis, serum CA 125 levels were significantly associated with BNP (standardized β coefficient=0.58, p<0.001) and LAVI (standardized β coefficient 0.34, p<0.005).

Conclusion: Our study demonstrates that elevated serum CA 125 levels are associated with increased LAVI in parallel to increased neurohormonal activation in patients with AHF.

Key Words: Carbohydrate antigen 125 • Left atrial volume • B-type natriuretic peptide • Advanced heart failure

Received February 16, 2008; Revised April 8, 2008; Accepted April 28, 2008


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.